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httpcense.Abstract Background: Few studies with small number of patients reported their experience with
ﬂexible ﬁberoptic bronchoscopy (FFB). We aimed to report our 7-year experience with the diagnos-
tic yield and complications of FFB at Assiut University Hospital.
Materials and methods: A retrospective review of bronchoscopy reports and corresponding
patients’ charts over 7 years from January 2006 to December 2012 performed at the Department
of Chest Diseases, Assiut University Hospital, was done. Indication for procedures, suspected diag-
nosis, ﬁnal diagnosis, and complications were reported.
Results: Of 3980 bronchoscopies, 3660 (92%) were diagnostic. Mean age was 45 ± 18 years and
68% were males. Malignancy and infection, including tuberculosis (TB), were the 2 main indica-li; aPTT, activated partial
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536 S.A.A. Mohamed et al.tions for FFB (47% and 23.8%). The overall diagnostic yield was 67%. A total of 1690 broncho-
alveolar lavage (BAL), 1303 brushing, 188 transbronchial biopsies (TBB), and 645 bronchial biop-
sies (BB) were performed. Malignancy was conﬁrmed in 70% of suspected cases. Tuberculosis was
diagnosed in 58.5% of suspected cases, whereas bacterial pneumonia was diagnosed in 48.5%.
Bronchoscopy diagnosed 38.4% of patients with interstitial lung disease. The diagnostic yield
was 55% for sarcoidosis and 33% for usual interstitial pneumonia. The overall complication rate
was 1.61%. Mortality rate was 0.05%.
Conclusions: Our results conﬁrm that ﬂexible ﬁberoptic bronchoscopy is a valuable diagnostic
tool, with a low rate of complications, particularly in patients with lung cancer. The diagnostic yield
in our locality is almost similar to that reported in other series.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
The ﬂexible ﬁberoptic bronchoscopy (FFB), has greatly
enhanced the diagnosis and understanding of lung diseases,
and has evolved into the most commonly used diagnostic
procedure in pulmonary medicine [1]. Several medical centers
all over the world have discussed their experience with the
diagnostic yield of FFB, with controversial results [1–4]. In
the developing countries however, there have been few reports
[5,6] of using bronchoscopy as a diagnostic procedure. More-
over, these reports are either descriptive or had a relatively
small number of patients. Therefore, the aim of this study is
to report our 7-year experience with the diagnostic yield and
complications of FFB at Assiut University Hospital, a tertiary
University hospital in Upper Egypt.
Methods
Patients
Assiut University hospital is a large tertiary referral hospital in
Upper Egypt, to which many patients are referred for diagnos-
tic bronchoscopy. All consecutive FFB were retrospectively
reviewed using bronchoscopy reports and corresponding pa-
tients’ charts over 7 years from January 2006 to December
2012, at the department of Chest Diseases, Assiut University
Hospital. The study was approved by the hospital’s ethics
committee and a written consent was obtained from each pa-
tient prior to the procedure.
Each FFB was completed by a pulmonary physician or a
fellow under a consultant’s supervision. Demographic data
were recorded including: age, gender, indication for procedure,
pre-medication, radiographic ﬁndings, suspected diagnosis,
bronchoscopy ﬁndings, ﬁnal diagnosis, and complications of
bronchoscopy. Suspected diagnosis was based on clinical and
radiographic ﬁndings whereas ﬁnal diagnosis was based on
microbiological and histopathological diagnosis. Patients
included outpatients as well as inpatients from our department
as well as different departments of the hospital.
Bronchoscopy procedure
Patients were maintained without oral intake for at least 6 h
prior to the procedure. Platelet count >60,000/lL was
ensured, along with normal prothrombin time (PT) and acti-
vated partial thromboplastin time (aPTT) which were requiredif transbronchial biopsy, endobronchial biopsy, or brushings
were performed. The procedure was performed using a ﬂexible
ﬁberoptic bronchoscopy (Pentax SB 15; Pentax, Japan) under
local anesthesia, via nasal or oral route with the patient lying
in supine position. In the situation of unstable or intubated
patients, the procedure was performed in the intensive care
unit (ICU). Subjects were premedicated with 0.4 mg IM atro-
pine 30–45 min prior to the procedure, except patients with
contraindications. Just before insertion of the bronchoscope,
2–3 ml of 2% viscous lidocaine was applied to the nose.
Midazolam (0.07 mg/kg) was administered intravenously in
incremental doses to achieve conscious sedation, before and
after the insertion of the bronchoscope.
All patients were supplemented with oxygen through nasal
cannula and were continuously monitored with electro-cardio-
gram and pulse oximetry. Liquid xylocaine 2% was adminis-
tered through the bronchoscope directly to the vocal cords
and the bronchial tree as needed.
During the bronchoscopic procedure, diagnostic materials
were obtained by bronchial washings (BW), bronchoalveolar
lavage (BAL), transbronchial needle aspiration (TBNA; lymph
nodes or lung), bronchial brushings, endobronchial biopsy or
transbronchial biopsy (TBB), as decided by the bronchoscopist
on a case-by-case basis. Bronchial secretions or washings were
obtained commonly during most procedures by instilling 10 ml
or more of sterile isotonic NaCl solution into the bronchus of
interest followed by immediate aspiration into a trap. Speci-
mens were sent to the laboratory for bacterial, fungal or viral
culture, and for cytological analysis. For bronchoalveolar
lavage, 3 · 50 ml of pyrogen-free-sterile 0.9% NaCl solution
was instilled into the middle lobe or lingual in patients with
diffuse disease and in patients with heterogeneous disease into
the segment with the most prominent radiological inﬁltrate.
BAL ﬂuid was recovered by suction or gravity. Centrifuged
BAL preparations were routinely stained with Giemsa and spe-
cial stains (e.g., silver methenamine for detection of fungi or
Pneumocystis jiroveci). Ten milliliter of BAL ﬂuid was sent
for bacterial, mycobacterial, and fungal culture and 5–10 ml
for viral culture. The rest was sent for cytology analysis.
Mouth ﬂora and Candida grown from BAL were not regarded
as relevant pathogens and therefore not included in the
analysis.
Transbronchial bronchial biopsy (TBB) was performed
blindly and as per the international recommendations [7].
Biopsy specimens were ﬁxed in formaldehyde solution, embed-
ded in parafﬁn, and sectioned. Post-bronchoscopy chest X-ray
was performed routinely 4 h after TBB. In situations where
Table 1 Diagnostic indications of bronchoscopy.
Indication No. of patient (%)
Suspected malignancy 1720 (47.0)
Suspected infection 870 (23.8)
Tuberculosis 513 (14.0)
Pneumonia 357 (9.8)
Hemoptysis 519 (14.0)
Abnormal radiological ﬁnding 390 (11.0)
Interstitial lung disease 294 (8.0)
Atelectasis 96 (3.0)
Others* 161 (4.2)
Total 3660 (100.0)
* Others; persistent cough, pleural effusion, evaluation of a
paralyzed hemidiaphragm.
3660 diagnostic
bronchoscopies
Diagnostic  2453 (67%)
Malignancy (n= 1720) 
       Confirmed 1204 (70%)  
Other diagnosis 313 (18.2%)
          Infection (n= 357) 
    Documented 173 (48.5%)
   Other  diagnosis 18 (5 %)
Tuberculosis (n= 513)
    Confirmed    300 (58.5%) 
Other diagnosis 213 ((41.5%) 
       Hemoptysis (n= 519) 
       Diagnostic 228 (44%)
 Abnormal radiological
finding (n=390)
 Diagnostic  183 (47%) 
          Others (n= 161) 
      Diagnostic 57 (36%)
Figure 1 Diagnostic yield of ﬂexible ﬁberoptic bronchoscopy.
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other procedures such as brushing, BW, and TBB, to avoid
contamination. A 13-mm 21-gauge cytology needle (NA-2C-
1; Olympus Corporation) was used for TBNA. Specimen han-
dling, cytopathology evaluation, and technical details of
TBNA have been described elsewhere [1]. Cytological speci-
mens were stained routinely by the Papanicolaou technique
and histological specimens were stained with hematoxylin
and eosin. All the specimens were interpreted by a cytopathol-
ogist. Rapid onsite pathology was not available. All subjects
were kept under constant supervision for post-bronchoscopy
complications including death, for 4 h following the procedure.
Complications were categorized as minor or major according
to the BTS guidelines [7].
Statistical analysis
Data collected were encoded into MS Excel 2010 for windows
XP professional. Age was presented as mean ± standard devi-
ation. Due to the descriptive nature of this study, all other data
were presented as percentages (%). Calculations and graphs
were done using Excel.
Results
A total of 4100 patients underwent FFB procedures. Eighty-
eight patients (2%) were excluded due to incomplete follow
up data. Only few number of patients, 32 (0.01%) underwent
bronchoscopic procedures at the ICU, were also excluded.
Of 3980 bronchoscopies, 3660 (92%) were diagnostic and
320 (8%) were therapeutic. Only results of diagnostic bron-
choscopies are shown in this study. The mean age was
45 ± 18 years and 2487 (68%) were males. Cigarette smokers
accounted for 66% of the studied patients. Indications for
diagnostic bronchoscopy are shown in Table 1.
Most of the diagnostic bronchoscopies were performed for
suspected malignancy (47%), followed by suspected infection
(23.8%). The overall diagnostic yield was 67% (2453/3660).
Of 3660 diagnostic bronchoscopies, a total of 1690 BAL,
1303 brushing, 188 TBB, and 645 BB were performed.
Of 1720 patients suspected to have malignancy, 1204 (70%)
patients were conﬁrmed, using various bronchoscopic proce-
dures, where BB were positive in 800 (66.4%), brushing in
651 (54%), and BAL in 513 (42.6%) patients. Endobronchial
malignancies were diagnosed in 845 patients (94.7%) out of892 who had a macroscopically visible tumor. Malignancy
was proved by other investigations (e.g. CT-guided biopsy,
surgical biopsy) in 203 (11.8%) patients. In the remaining
313 (18.2%) patients, an alternative diagnosis was found,
which included infection, granulomatous disease, interstitial
pulmonary disease, aspiration pneumonia, and nonspeciﬁc
inﬂammation.
Pneumonia was suspected in 357 (9.8%) patients, while 513
(14%) were suspected for active TB. Bacterial pneumonia was
diagnosed microbiologically in 173 (48.5%), P. jiroveci pneu-
monia in 5 (1.4%), and Candida species in 28 (7.8%) patients.
In 18 (5%) patients, an alternative diagnosis was conﬁrmed,
mainly TB and 5 patients had interstitial lung disease (ILD).
In the remaining 133 (37.3%) samples, no organisms were
isolated.
Overall, FFB was diagnostic of pulmonary TB in 300
(58.5%) patients. On the other hand, TB was excluded in
213 (41.5%) patients, out of whom 87 (17%) patients were
treated for pneumonia. BAL of 126 (42%) samples (38 of them
(30%) were smear-negative sputum) were positive with Acid
fast bacilli (AFB) stain whereas, BAL culture was positive in
165 (46.2%) samples. TBB revealed a histopathologic diagno-
sis consistent with TB granuloma in 23 (6.4%) patients.
For patients bronchoscoped due to hemoptysis, 228 (44%)
were conﬁrmed to have existing pathology; 126 with malig-
nancy, 34 with pneumonia, 26 with chronic bronchitis, 21 with
tuberculosis, 16 with nonspeciﬁc inﬂammation, and 5 with
granulomatous disease.
Out of 390 patients with abnormal radiologic ﬁnding, 294
had ILD whereas 96 had atelectasis. (Table 1) FFB conﬁrmed
the diagnosis of ILD in 113 (38.4%) patients via the use of
TBB. Diagnostic yields of 48/145 (33%), 21/54 (39%), 21/45
(47%), 14/30 (46.7%), 6/11 (55%), and 3/9 (33.3%), were re-
Table 2 Complications of diagnostic bronchoscopy.
Complication No. of patient (%)
Minor
Bronchospasm 22 0.6
Epistaxis 4 0.11
Laryngospasm 9 0.24
Total 35 0.95
Major
Pulmonary hemorrhage* 4 0.11
Pneumothorax 8 0.22
Respiratory failure 12 0.33
Total 24 0.66
Death 2 0.05
* Pulmonary hemorrhage; more than 50 ml.
538 S.A.A. Mohamed et al.ported for patients with UIP, non speciﬁc interstitial pneumo-
nitis, bronchiolitis obliterans organizing pneumonia (BOOP),
hypersensitivity pneumonitis, sarcoidosis and eosinophilic
pneumonia, respectively.
For those 96 patients with atelectasis, 70 (73%) were con-
ﬁrmed to have existing pathology; 48 with malignancy, 11 with
mucus plugs or impacted secretions, 7 with nonspeciﬁc inﬂam-
mation, and 4 with granulomatous disease. A summary of the
diagnostic yield of FFB is given in Fig. 1. Complications of
bronchoscopy are shown in Table 2.
Discussion
In this study, a retrospective analysis of 3660 consecutive diag-
nostic bronchoscopies was performed at a tertiary care Univer-
sity hospital in Upper Egypt over a period of 7 years. To the
best of our knowledge, this work represents the largest ever
study evaluating the diagnostic yield and complications of
FFB in a developing or Middle East country through a 7-year
period.
Although the indications for diagnostic bronchoscopy
remained the same, different regions may have different prior-
ities. Our ﬁndings are in agreement with those reports from
Western countries [8], where malignancy was the most com-
mon indication for bronchoscopy. On the contrary, our results
disagree with those of neighboring countries [2,9] where infec-
tion was the most common indication for bronchoscopy,
followed by malignancy. Suspected malignancy, being the
most common indication for FFB in our records, can be
explained by the observations that 68% and 66% of our
cohorts were males, and cigarette smokers, respectively. The
current study conﬁrms the importance of FFB in the diagnosis
of different pulmonary diseases. Our results revealed an overall
diagnostic yield of 67% and a yield of 70% for detecting
malignancy.
Several authors had reported the diagnostic yield of FFB,
with controversial results. Joos et al. [1] and Alzeer et al. [2] re-
ported yields of 57% and 58%, among 430 and 592 patients,
respectively. Whereas, Bhadke et al. [5] and Fein et al. [4]
reported yields of 75% and 86%, among 120 and 14 patients,
respectively. These discrepancies might be explained by differ-
ences in patients’ numbers and demographics, methods oflaboratory and pathologic diagnoses, and statistical analysis.
The relatively higher yield of FFB in the present study could
be explained by the fact that our Department caters to millions
of population all over Upper Egypt, hence the resulting pres-
sure on the facility leads to the use of FFB in patients who
are more likely to have an underlying pathology.
Our results showed an overall 70% diagnostic yield of FFB
for detecting malignancy, which increased to 94.7% for macro-
scopically visible tumors. Positive rates of 66.4%, 54%, and
42.6% were reported for BB, brushing, and BAL, respectively.
These data are in concordance with those published by Schre-
iber et al. who conducted a systematic analysis of 30 studies of
patients with central cancer lesions. Endobronchial biopsies
provided the highest sensitivity (0.74; 20 studies), followed
by brushings (0.59; 18 studies) and washings (0.48; 12 studies).
The overall sensitivity for all bronchoscopic modalities com-
bined, was 0.88 for centrally located endobronchial disease
(14 studies) [10].
Our data revealed that bacterial pneumonia was diagnosed
in 48.5% of patients bronchoscoped for suspected infection.
Other studies reported similar results [1,2,5], yet with smaller
numbers of enrolled patients. The infection due to Candida
species has become more frequent in immunocompromised
patients like those with HIV, diabetes mellitus, and those on
immunosuppressive drug and corticosteroids. We reported
fungal infection due to Candida species in 28 (7.8%) patients.
These patients were diabetic and had cavitary lesion(s) on
chest radiography.
Many studies [1,2,11,12] had established the utility of FFB
in the diagnosis of pulmonary TB. FFB can be particularly
useful in patients with smear-negative or absent sputum, and
in those with endobronchial TB [11–13]. Shin and coworkers
[14] reported sensitivity, speciﬁcity, positive predictive value,
and negative predictive value for FFB of 75.9%, 97.2%,
95.3%, and 84.3%, respectively, for the rapid diagnosis of
active pulmonary TB (PTB). Recently, Quaiser et al. [15],
concluded that FFB is a useful tool in diagnosing sputum
smear-negative PTB, and identiﬁes individuals at a higher risk
of disease progression at an early stage, despite not meeting
routine bacteriological criteria for conﬁrmation of PTB. Our
data support the usefulness of FFB in the diagnosis of pulmon-
ary TB. We found an overall diagnostic yield of 58.5%. BAL
samples were positive with AFB stain and culture in 42% and
46.2% patients, respectively. Notably 30% of positive samples
for AFB stain were for patients with smear-negative sputum.
With regard to patients with ILD, diagnostic yields of 33%,
47%, and 55%, were reported for patients with UIP, BOOP,
and sarcoidosis, respectively. Our data are in agreement with
those reported by several authors [2,9,16], and conﬁrm the
importance of transbronchial biopsy in diagnosing ILD. In
patients with suspected ILD, more invasive diagnostic proce-
dures such as thoracoscopic or open lung biopsies could be
avoided and therefore, limiting the costs and morbidity.
Bronchoscopy-related complications were rare in the cur-
rent study. We reported rates of 0.95%, 0.66%, and 0.05%
for minor, major complications, and mortality, respectively.
Notably, pneumothorax occurred in 0.22%, and was associ-
ated exclusively with TBB. Previous reports had shown that
the rate of pneumothorax varied between 0.08% and 5%
[17]. This low rate of pneumothorax is better than that re-
ported by other studies [2] and supports those studies which
Diagnostic utility and complications of ﬂexible ﬁberoptic bronchoscopy in Assiut University Hospital: A 7-years experience 539concluded that TBB without ﬂuoroscopy is a safe procedure
particularly in sarcoidosis and diffuse neoplasm [18].
Recently, a survey was conducted by the Japan Society for
Respiratory Endoscopy [19] for the safety of endoscopy. The
total number of diagnostic FFB procedures performed was
103978, and 4 patients died (0.004%). The complication rate
according to lesion ranged from 0.51% to 2.06%, with the
highest rate being observed in patients with diffuse lesions.
The complication rate according to the procedure ranged from
0.17% to 1.93%, with the highest rate being observed in pa-
tients who underwent forceps biopsy. Overall, our reported
rates of complications and mortality are more favorable than
those reported in the literature [2,20] and conﬁrm the safety
of FFB and its routine procedures.
The last decades have seen introduction of several diagnos-
tic innovations in the bronchoscopy suite, such as endobron-
chial ultrasound bronchoscopes, EBUS [21], navigation
systems [22], hot biopsy forceps, and cryobiopsy [23]. These
modalities were introduced with the aim to increase the diag-
nostic yield of bronchoscopy. However, such innovations are
mainly limited to specialized centers and do not reﬂect the
application of this technique in routine clinical practice [1].
Overall, ﬁndings of the current study conﬁrm our belief that
the diagnostic yield of FFB and its routine techniques are high,
particularly in lung cancer patients and hence they should be
continued to be optimally applied in patient management, par-
ticularly in developing countries. Although cost analysis was
not carried out in the current study, our results could have
important implications with regard to bronchoscopic manage-
ment of patients with various respiratory diseases. The opti-
mum use of conventional bronchoscopy and its techniques in
the hands of experienced bronchoscopiests, with the adherence
to the international guidelines for performing these techniques
[7,24] will improve diagnostic outcomes of those patients with
the least morbidity and mortality, employing better therapeu-
tic strategies, and thus improving the overall management of
those patients.
Possible limitations of this study such as data maybe biased
selection, is related to its retrospective nature. Further pro-
spective studies in the future may be needed to highlight the
new diagnostic bronchoscopic interventions.Conclusions
To conclude, results of this study conﬁrm that ﬂexible ﬁberop-
tic bronchoscopy is a valuable diagnostic tool, with a low rate
of complications, particularly in patients with lung cancer. The
diagnostic yield in our institution is almost similar to that
reported in other series.Competing interests
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